Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Wetzel

Orthopaedic Trauma Cleveland, OH Medical Doctor

NPI 1760610794 CMS profile 698705

11100 Euclid Ave, Cleveland, OH 44106

Open in the dashboard

General payments

$573,896

582 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Wetzel of Cleveland, OH is reported in the CMS Open Payments database as having received $573,896 across 582 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $164,645 150
2024 General $130,265 118
2023 General $105,723 103
2022 General $80,223 71
2021 General $40,534 35
2020 General $7,368 24
2019 General $45,137 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Wetzel
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Robert Wetzel were reported at $164,645. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Robert Wetzel Orthopaedic Trauma median Middle half National median
2019 $45,137 $1,475 $264–$6,401 $163
2020 $7,368 $596 $120–$4,020 $114
2021 $40,534 $919 $171–$4,697 $132
2022 $80,223 $1,547 $272–$7,240 $149
2023 $105,723 $1,330 $247–$5,875 $160
2024 $130,265 $1,288 $277–$6,797 $164
2025 $164,645 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $348,041 403 payments
  2. Royal Biologics $154,845 37 payments
  3. CurvaFix, Inc. $26,455 19 payments
  4. Biocomposites Inc $26,155 26 payments
  5. Medacta USA, Inc. $9,509 22 payments
  6. Smith+Nephew, Inc. $6,150 51 payments
  7. Philips Electronics North America Corporation $1,200 1 payment
  8. Rock Medical Orthopedics, Inc. $688 10 payments
  9. Arthrex, Inc. $273 2 payments
  10. OsteoCentric Technologies, Inc. $159 1 payment
  11. Other $421 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $326,597 112 payments
  2. Royalty or License $133,511 16 payments
  3. Travel and Lodging $72,506 195 payments
  4. Honoraria $24,375 12 payments
  5. Food and Beverage $13,961 241 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,593 3 payments
  7. Education $353 3 payments
Products named General payments · program years 2019–2025
  1. AXSOS $146,443 64 payments
  2. GAMMA $117,815 72 payments
  3. AUGMENT INJECTABLE $77,659 39 payments
  4. HOFFMANN $76,506 36 payments
  5. T2 Trauma & Extremeties $75,718 38 payments
  6. INBONE $43,166 19 payments
  7. VARIAX $40,590 20 payments
  8. T2 Trauma & Extremeties $35,111 37 payments
  9. PANGEA $29,646 51 payments
  10. CurvaFix IM Implant $26,455 19 payments
  11. Other $222,247 369 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$83,738

Medicare's payments for the services billed

Medicare patients

134

Average age 76

Services billed

409

91 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 68%
Ischemic heart disease 37%
Chronic kidney disease 36%
Depression 33%
Heart failure 32%
Diabetes 31%
Osteoporosis 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

582 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record